Current Studies in Follow-up

Title: Immune Response to BK Virus Infection in Renal Transplant Recipients
PI: Sundaram Hariharan, MD
Sponsor: Internal

Title: Pathogenesis of BKV Nephritis in Human Renal Transplant Recipients
PI: Sundaram Hariharan, MD
Sponsor: Internal

Title: A multicenter, phase 2, open-label, controlled, extension study for Stage 1 subjects of study A3921009 to evaluate the long-term safety and efficacy of CP-690,550 vrsus tacrolimus, when co-administered with mycophenolate mofetil in renal allograft recipients (A3921021)
PI: Sundaram Hariharan, MD
Sponsor: Pfizer

Title: Belatacept Evaluation of Nephro protection and efficacy as First-line Immunosuppression Trial (Benefit Clinical Protocol: IMI03008
PI: Barbara Bresnahan, MD
Sponsor: BMS

Title: 271-03 A Phase III, Randomized, Open-Label, Comparative, Multicenter Study to Assess the Safety and Efficacy of Prograf (tacrolimus)/MMF, Modified Release (MR) Tacrolimus/MMF and Neoral (cyclosporine)/MMF in de novo Kidney Transplant Recipients (02-0-158)
PI: Barbara Bresnahan, MD
Sponsor: Astellas

Title: 194-02 A randomized, controlled clinical trial of the Effect of a High Dose Combination of Folic Acid, Vitamin B6, Vitamin B12 on Arteriosclerotic Cardiovascular Disease Outcomes in Chronic, Stable Renal Transplant Recipients
PI: Barbara Bresnahan, MD
Sponsor: Rhode Island University

Title: Renal Transplantation, Homocysteine Lowering and Cognition.  An ancillary study of the FAVORIT trial.
PI: Barbara Bresnahan, MD
Sponsor: Rhode Island University